Actively Recruiting
Preventive Pregabalin Treatment to Stop Central Pain in Adults After Spinal Cord Injury
Led by Loewenstein Hospital · Updated on 2025-06-24
50
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
This research aims to evaluate the impact of preventative drug therapy on pain regulation in patients with spinal cord injuries who have not yet developed central pain. The study focuses on patients arriving for rehabilitation within three months after spinal cord injury, either traumatic or non-traumatic, and seeks to understand how early intervention may influence the development of central pain. Participants are divided into two groups one group receives Pregabalin 75 mg twice daily for three months as a preventative treatment, while the control group does not receive any preventative medication. The study observes these patients over time to monitor the onset and progression of central pain. During the study, participants will be followed up for one year, with assessments including the McGill Pain Questionnaire at three months and evaluation of central pain development at one year. The study team will monitor participants pain symptoms and overall condition, ensuring adherence to the treatment plan and tracking outcomes related to pain regulation.
CONDITIONS
Brief Title
Prophylactic Pregabalin Treatment Following Spinal Cord Injury
Research Team
A
Amiram Catz, Prof.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
